RHC — Ramsay Health Care Share Price
Last trade - 00:00- AU$7.64bn
- AU$19.18bn
- AU$16.67bn
- 74
- 60
- 67
- 74
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 22.37 | ||
| PEG Ratio (f) | 1.07 | ||
| EPS Growth (f) | 26.39% | ||
| Dividend Yield (f) | 2.85% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.59 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 11.66 | ||
| Price to Sales | 0.45 | ||
| EV to EBITDA | 10.71 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.05% | ||
| Return on Equity | 0.17% | ||
| Operating Margin | 4% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 11,983.4 | 12,442.6 | 13,210.2 | 15,002.1 | 16,667.2 | 17,689.35 | 18,535.55 | 7.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -94.1 | n/a | n/a | n/a | n/a | +34.56 | +24.98 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ramsay Health Care Limited is a provider of hospital and healthcare services in Australia, Europe and the United Kingdom. Its segments include Australia, the UK, France and the Nordics. Its businesses include Ramsay Australia, Ramsay Sante, Ramsay UK, and Elysium Healthcare. Ramsay Health Care is Australia’s private hospital operator, with more than 70 modern hospitals, clinics and surgical centers in cities and towns across the country. Ramsay Sante is a private care provider in Europe with hundreds of modern hospitals, clinics, primary care and imaging centers across France, Sweden, Norway, Denmark and Italy. Ramsay UK has a network of hospitals and day surgeries across the UK providing a range of clinical specialties to private and self-insured patients. Elysium Healthcare is an independent provider of specialist health and care services. Elysium's four core service streams are mental health and wellbeing, learning disabilities and autism, neurological, and children and education.
Directors
- Michael Siddle NEC
- Craig McNally CEO
- Martyn Roberts CFO
- Henrietta Rowe GCN
- David Thodey LED
- Steven Sargent NED (60)
- Alison Deans NID (53)
- Claudia Dyckerhoff NID
- James McMurdo NID
- Karen Penrose NID
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 26th, 1975
- Public Since
- September 24th, 1997
- No. of Employees
- 90,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 228,800,000
- Address
- Level 18, 126 Phillip Street, SYDNEY, 2000
- Web
- https://www.ramsayhealth.com/
- Phone
- +61 292201000
- Auditors
- Ernst & Young Australia
Latest News for RHC
Upcoming Events for RHC
Full Year 2025 Ramsay Health Care Ltd Earnings Release
Similar to RHC
Apiam Animal Health
Australian Stock Exchange - SEATS
Artrya
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
Cann
Australian Stock Exchange - SEATS
Careteq
Australian Stock Exchange - SEATS
FAQ
As of Today at 22:50 UTC, shares in Ramsay Health Care are trading at AU$33.39. This share price information is delayed by 15 minutes.
Shares in Ramsay Health Care last closed at AU$33.39 and the price had moved by -34.63% over the past 365 days. In terms of relative price strength the Ramsay Health Care share price has underperformed the ASX All Ordinaries Index by -35.61% over the past year.
The overall consensus recommendation for Ramsay Health Care is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Ramsay Health Care dividend yield is 2.4% based on the trailing twelve month period.
Last year, Ramsay Health Care paid a total dividend of AU$0.80, and it currently has a trailing dividend yield of 2.4%. We do not have any data on when Ramsay Health Care is to next pay dividends.
We do not have data on when Ramsay Health Care is to next pay dividends. The historic dividend yield on Ramsay Health Care shares is currently 2.4%.
To buy shares in Ramsay Health Care you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$33.39, shares in Ramsay Health Care had a market capitalisation of AU$7.64bn.
Here are the trading details for Ramsay Health Care:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: RHC
Based on an overall assessment of its quality, value and momentum Ramsay Health Care is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Ramsay Health Care is AU$39.81. That is 19.24% above the last closing price of AU$33.39.
Analysts covering Ramsay Health Care currently have a consensus Earnings Per Share (EPS) forecast of AU$1.24 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ramsay Health Care. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -16.71%.
As of the last closing price of AU$33.39, shares in Ramsay Health Care were trading -13.94% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ramsay Health Care PE ratio based on its reported earnings over the past 12 months is 22.37. The shares last closed at AU$33.39.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ramsay Health Care's management team is headed by:
- Michael Siddle - NEC
- Craig McNally - CEO
- Martyn Roberts - CFO
- Henrietta Rowe - GCN
- David Thodey - LED
- Steven Sargent - NED
- Alison Deans - NID
- Claudia Dyckerhoff - NID
- James McMurdo - NID
- Karen Penrose - NID